These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11167918)

  • 41. Genetics and pharmacogenetics of osteoporosis.
    Carbonell Sala S; Masi L; Marini F; Del Monte F; Falchetti A; Franceschelli F; Brandi ML
    J Endocrinol Invest; 2005; 28(10 Suppl):2-7. PubMed ID: 16550715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Has the gene for osteoporosis really been identified?
    Marcelli C
    Rev Rhum Engl Ed; 1996 Jun; 63(6):445-9. PubMed ID: 8817755
    [No Abstract]   [Full Text] [Related]  

  • 43. How about vitamin D receptor polymorphisms?
    Pols HA; Uitterlinden AG; van Leeuwen JP
    Osteoporos Int; 1998; 8 Suppl 2():S20-3. PubMed ID: 10197178
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic markers, bone mineral density, and serum osteocalcin levels.
    Sowers M; Willing M; Burns T; Deschenes S; Hollis B; Crutchfield M; Jannausch M
    J Bone Miner Res; 1999 Aug; 14(8):1411-9. PubMed ID: 10457274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The genetics of osteoporosis.
    Williams FM; Spector TD
    Acta Reumatol Port; 2007; 32(3):231-40. PubMed ID: 17940498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteoporosis, genetics and hormones.
    Rizzoli R; Bonjour JP; Ferrari SL
    J Mol Endocrinol; 2001 Apr; 26(2):79-94. PubMed ID: 11241160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The golem of osteoporosis genetics.
    Patel MS; Cole DE; Rubin LA
    J Rheumatol; 1998 May; 25(5):831-4. PubMed ID: 9598875
    [No Abstract]   [Full Text] [Related]  

  • 48. Association of otosclerosis with Sp1 binding site polymorphism in COL1A1 gene: evidence for a shared genetic etiology with osteoporosis.
    McKenna MJ; Nguyen-Huynh AT; Kristiansen AG
    Otol Neurotol; 2004 Jul; 25(4):447-50. PubMed ID: 15241219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic control of susceptibility to osteoporosis.
    Ralston SH
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2460-6. PubMed ID: 12050200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and environmental determinants of peak bone mass in young men and women.
    McGuigan FE; Murray L; Gallagher A; Davey-Smith G; Neville CE; Van't Hof R; Boreham C; Ralston SH
    J Bone Miner Res; 2002 Jul; 17(7):1273-9. PubMed ID: 12096841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.
    Kurabayashi T; Tomita M; Matsushita H; Yahata T; Honda A; Takakuwa K; Tanaka K
    Am J Obstet Gynecol; 1999 May; 180(5):1115-20. PubMed ID: 10329864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advances in the research of vitamin D receptor gene].
    Xu B; Wang BJ
    Fa Yi Xue Za Zhi; 2005 Feb; 21(1):55-7, 60. PubMed ID: 15895809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphism at an Sp1 binding site of COL1A1 and bone mineral density in premenopausal female twins and elderly fracture patients.
    Hustmyer FG; Liu G; Johnston CC; Christian J; Peacock M
    Osteoporos Int; 1999; 9(4):346-50. PubMed ID: 10550452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The genetics of osteoporosis: vitamin D receptor polymorphisms.
    Wood RJ; Fleet JC
    Annu Rev Nutr; 1998; 18():233-58. PubMed ID: 9706225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Osteoporosis].
    Hosoi T
    Nihon Ika Daigaku Zasshi; 1999 Oct; 66(5):327-8. PubMed ID: 10548002
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic determination of osteoporosis in Chinese.
    Xiao SM; Lei SF; Deng HW
    Chin Med J (Engl); 2005 Dec; 118(24):2077-88. PubMed ID: 16438906
    [No Abstract]   [Full Text] [Related]  

  • 57. [Estrogen receptor gene polymorphisms].
    Kurabayashi T; Matsushita H; Tomita M; Yahata T; Tanaka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():164-8. PubMed ID: 15035118
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacogenetics of bone treatments: the VDR and ERalpha gene story.
    Massart F; Marcucci G; Brandi ML
    Pharmacogenomics; 2008 Jun; 9(6):733-46. PubMed ID: 18518851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women.
    Aerssens J; Dequeker J; Peeters J; Breemans S; Broos P; Boonen S
    Osteoporos Int; 2000; 11(7):583-91. PubMed ID: 11069192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphism of VDR gene--the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland.
    Horst-Sikorska W; Wawrzyniak A; Celczyńska-Bajew L; Marcinkowska M; Dabrowski S; Kalak R; Słomski R
    Endokrynol Pol; 2005; 56(3):233-9. PubMed ID: 16350715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.